NCT03617549

Brief Summary

The overall goal of this research is to clarify the relationship between reported maternal stress, biological measures of maternal stress, breast milk biomarkers and milk quantity. Our primary hypothesis is that measures of maternal stress are associated with cortisol, cytokines, and other stress markers in the blood, which impacts breast milk quantity and composition and which may impact infant health.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 1, 2018

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 6, 2018

Completed
10 months until next milestone

Study Start

First participant enrolled

June 1, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2020

Completed
Last Updated

August 3, 2020

Status Verified

July 1, 2020

Enrollment Period

10 months

First QC Date

August 1, 2018

Last Update Submit

July 30, 2020

Conditions

Keywords

neonatal intensive care

Outcome Measures

Primary Outcomes (2)

  • Correlation between secretory IgA levels in mother's serum and reported stress

    Mother's stress will be measured using the The Parent Stress Scale: Neonatal Intensive Care Unit. This scale ranges from 1-130 with higher numbers indicating more stress. Serum will be collected from mothers at enrollment and 4 weeks postpartum. Maternal venipuncture will be used to collect an 0.5mL aliquot of whole blood at the time of mother's first morning pump session in the neonatal intensive care unit. IgA will be quantitated using the Millipore Magpix 100 System. Multivariate regression analysis will be used to test for correlations.

    baseline

  • Correlation between secretory IgA levels in mother's serum and reported stress

    Mother's stress will be measured using the The Parent Stress Scale: Neonatal Intensive Care Unit. This scale ranges from 1-130 with higher numbers indicating more stress. Serum will be collected from mothers at enrollment and 4 weeks postpartum. Maternal venipuncture will be used to collect an 0.5mL aliquot of whole blood at the time of mother's first morning pump session in the neonatal intensive care unit. IgA will be quantitated using the Millipore Magpix 100 System. Multivariate regression analysis will be used to test for correlations.

    1 month

Study Arms (1)

All Participants

Mothers of singleton moderate preterm appropriate for Gestational Age (AGA) infants (29-32+6 weeks gestation in the neonatal intensive care unit at the Golisano Children's Hospital

Eligibility Criteria

Sexfemale
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Mothers of singleton moderate preterm appropriate for Gestational Age (AGA) infants (29-32+6 weeks gestation29) will be approached during the enrollment period and screened for eligibility.

You may qualify if:

  • Baby will remain in mom's legal custody
  • Intends to exclusively breastfeed during the NICU stay
  • Has kept a daily log of milk expression (pump or hand expression) with date/time/quantity since birth of their child
  • Less than 7 days postpartum

You may not qualify if:

  • Baby and mother are to be separated due to legal custody issues
  • Medical contraindication to breastfeeding
  • Non-English speaking
  • Unable to answer a written survey in English
  • More than 50% of infant intake is not mother's own milk at 4 weeks postpartum

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Rochester Medical Center NICU

Rochester, New York, 14642, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

serum, saliva, breastmilk

MeSH Terms

Conditions

Breast FeedingBreast Milk Expression

Condition Hierarchy (Ancestors)

Feeding BehaviorBehavior

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 1, 2018

First Posted

August 6, 2018

Study Start

June 1, 2019

Primary Completion

March 30, 2020

Study Completion

March 30, 2020

Last Updated

August 3, 2020

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will not share

Locations